Biomedical Engineering Reference
In-Depth Information
Gonzalez-Martin G, Merino I, Rodriguez-Cabezas MN, Torres M, Nuñez R, Osuna A (1998)
Characterization and trypanocidal activity of nifurtimox-containing and empty nanoparticles
of polyethylcyanoacrylates. J Pharm Pharmacol 50: 29-35
Gonzalez-Martín G, Figueroa C, Merino I, Osuna A (2000) Allopurinol encapsulated in polycy-
anoacrylate nanoparticles as potential lysosomatropic carrier: preparation and trypanocidal
activity. Eur J Pharm Biopharm 49: 137-142
Goodyer ID, Pouvelle B, Schneider TG, Trelka DP, Taraschi TF (1997) Characterization of mac-
romolecular transport pathways in malaria-infected erythrocytes. Mol Biochem Parasitol 87:
13-28
Gradoni L, Davidson RN, Orsini S, Betto P, Giambenedetti M (1993) Activity of liposomal ampho-
tericin B (AmBisome) against Leishmania infantum and tissue distribution in mice. J Drug
Target 1: 311-316
Grassl GA, Finlay BB (2008) Pathogenesis of enteric Salmonella infections. Curr Opin
Gastroenterol 24: 22-26
Grayston JT, Kuo CC, Campbell LA, Wang SP (1989) Chlamydia pneumoniae sp. nov. for
Chlamydia sp. strain TWAR. Int J Syst Bacteriol 39: 88-90
Grayston JT, Aldous MB, Easton A, Wang SP, Kuo CC, Campbell LA, Altman J (1993) Evidence
that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis 168: 1231-1235
Greenwood BM, Fidock DA, Kyle DE, Kappe SHI, Alonso PL, Collins FH, Duffy PE (2008)
Malaria: Progress, perils, and prospects for eradication. J Clin Invest 118: 1266-1276
Groisman EA (1997) How Salmonella became a pathogen. Trends Microbiol 5: 343-349
Gupta R, Kim JY, Espinal MA, Caudron J-M, Pecoul B, Farmer PE, Raviglione MC (2001)
Responding to market failures in tuberculosis control. Science 293: 1049-1051
Gupta Y, Jain A, Jain SK (2007) Transferrin-conjugated solid lipid nanoparticles for enhanced
delivery of quinine dihydrochloride to the brain. J Pharm Pharmacol 59: 935-940
Guru PY, Agrawal AK, Singha UK, Singhal A, Gupta CM (1989) Drug targeting in Leishmania
donovani infections using tuftsin-bearing liposomes as drug vehicles. FEBS Lett 245:
204-208
Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V (2004) Autophagy is a
defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected mac-
rophages. Cell 119: 753-766
Gutiérrez Millán C, Castañeda AZ, López FG Marinero ML, Lanao JM, Arévalo M (2005)
Encapsulation and in vitro evaluation of amikacin-loaded erythrocytes. Drug Deliv 12:
409-416
Gutiérrez Millán C, Castaneda AZ, López FG, Marinero ML, Lanao JM (2008) Pharmacokinetics
and biodistribution of amikacin encapsulated in carrier erythrocytes. J Antimicrobial
Chemother 61: 375-381
Haas SE, Bettoni CC, de Oliveira LK, Guterres SS, Dalla Costa T (2009) Nanoencapsulation
increases quinine antimalarial efficacy against Plasmodium berghei in vivo . Int J Antimicrob
Agents 34: 156-161
Hammerschlag MR, Chirgwing K, Roblin PM, Gelling M, Dumornay W, Mandel L, Smith P,
Schachter J (1992) Persistent infection with Chlamydia pneumoniae following acute respira-
tory illness. Clin Infect Dis 14: 178-182
Hanan MS, Riad EM, el-Khouly NA (2000) Antibacterial efficacy and pharmacokinetic studies of
ciprofloxacin on Pasteurella multocida infected rabbits. Dtsch Tierarztl Wochenschr 107:
151-155
Hand WL, King-Thompson N, Holman JW (1987) Entry of roxithromycin (RU 965), imipenem,
cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes,
Antimicrob Agents Chemother 31(10): 1553-1557
Haynes SM, Longmuir KJ, Robertson RT, Baratta JL, Waring AJ (2008) Liposomal polyethyle-
neglycol and polyethyleneglycol-peptide combinations for active targeting to liver in vivo .
Drug Deliv 15: 207-217
Herwaldt BL (1999) Leishmaniasis. Lancet 354: 1191-1199
Hickey AJ, Martonen TB, Yang Y (1996) Theoretical relationship of lung deposition to the fine
particle fraction of inhalation aerosols. Pharm Acta Helv 71: 185-190
Search WWH ::




Custom Search